Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
P/E Ratio
--
P/B Ratio
49.59
Industry P/E
87.38
Debt to Equity
0
ROE
-1.87 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-21.54 Mln
EBITDA
$-31.57 Mln
Net Profit
$-18.30 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Sharps Technology Inc (STSS)
| -99.19 | -60.22 | -96.42 | -99.73 | -91.64 | -- | -- |
BSE Sensex
| 2.61 | 3.71 | 5.78 | 8.89 | 11.76 | 20.11 | 11.35 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2024
|
2023
|
|
---|---|---|
Sharps Technology Inc (STSS)
| -77.22 | -65.62 |
S&P Small-Cap 600
| 7.01 | 13.89 |
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
---|---|---|---|---|
12.66 | 10,562.04 | 12.43 | 12.69 | |
72.81 | 10,050.19 | 97.07 | 2.52 | |
296.92 | 11,609.25 | 277.57 | 3.65 | |
117.67 | 14,455.82 | 41.45 | 5.44 |
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe... products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York. Address: 105 Maxess Road, Melville, NY, United States, 11747 Read more
CEO & Director
Mr. Robert M. Hayes
CEO & Director
Mr. Robert M. Hayes
Headquarters
Melville, NY
Website
The total asset value of Sharps Technology Inc (STSS) stood at $ 10 Mln as on 31-Mar-25
The share price of Sharps Technology Inc (STSS) is $5.01 (NASDAQ) as of 29-Apr-2025 12:38 EDT. Sharps Technology Inc (STSS) has given a return of -91.64% in the last 3 years.
Sharps Technology Inc (STSS) has a market capitalisation of $ 0 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Sharps Technology Inc (STSS) is 49.59 times as on 28-Apr-2025, a 1281% premium to its peers’ median range of 3.59 times.
Since, TTM earnings of Sharps Technology Inc (STSS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Sharps Technology Inc (STSS) and enter the required number of quantities and click on buy to purchase the shares of Sharps Technology Inc (STSS).
Sharps Technology, Inc., a medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States. The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems. The company was incorporated in 2017 and is based in Melville, New York. Address: 105 Maxess Road, Melville, NY, United States, 11747
The CEO & director of Mr. Robert M. Hayes. is Sharps Technology Inc (STSS), and CFO & Sr. VP is Mr. Robert M. Hayes.
There is no promoter pledging in Sharps Technology Inc (STSS).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|---|
1,126
|
|
1,078
|
|
1,054
|
|
964
|
Sharps Technology Inc (STSS) | Ratios |
---|---|
Return on equity(%)
|
-302.06
|
Operating margin(%)
|
--
|
Net Margin(%)
|
--
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Sharps Technology Inc (STSS) was $0 Mln.